Key result
Grade 3-4 heart failure linked to ~566% higher mortality after ICI-associated myocarditis.
Why the study?
ICI-associated myocarditis is fatal and prone to affecting multiple organ systems, but multi-organ irAEs have not been fully studied in this setting.
Does the presence of multi-organ immune-related adverse events impact overall survival and disease severity in cancer patients with ICI-associated myocarditis?
Observational (n=46)
Yes
Does the presence of multi-organ immune-related adverse events impact overall survival and disease severity in cancer patients with ICI-associated myocarditis?
In cancer patients with ICI-associated myocarditis, concurrent multi-organ irAEs are common and associated with more severe heart failure, which independently predicts poor overall survival.
Answers are grounded in this paper and cite their sources.
Severe HF signals higher mortality in ICI-myocarditis; hypothesis-generating for multi-organ irAEs, needs prospective validation.
Background and Objective: Immune checkpoint inhibitor (ICI)-associated myocarditis is a fatal immune-related adverse events (irAEs), which is prone to affecting multiple organ systems. Multi-organ irAEs have not been fully studied in ICI-associated myocarditis. Therefore, we aimed to explore the impact of multi-organ irAEs on ICI myocarditis in terms of clinical features, treatment, and prognosis. Methods: This was a retrospective study. The clinical data of ICI myocarditis patients were collected from 6 hospitals in China. The risk factors and characteristics of pure myocarditis and multi-organ irAEs were analyzed. The overall survival (OS) after myocarditis was analyzed and univariate and multivariate regression analysis were performed. Results: A total of 46 patients were analyzed in this study. Multi-organ irAEs were common (30/46, 65.2%) and prone to severe heart failure. The severe myocarditis was observed in 32 patients (69.6%). When myocarditis occurred, neutrophil to lymphocyte ratio, C-reactive protein, lactate dehydrogenase, interleukin (IL)-6, IL-10, creatine kinase, MB isoenzyme of creatine kinase, and brain natriuretic peptide increased from baseline, but absolute lymphocyte count decreased. Thymoma (B2/B3) was a risk factor for multi-organ irAEs. Heart failure and myocarditis were more severe in patients with multi-organ irAEs and require early corticosteroid therapy (<24 hours). Univariate analysis showed that age ≥ 60 years, myocarditis (grade 3-4), heart failure (grade 3-4), multi-organ irAEs, and severe myocarditis were associated with OS after myocarditis. After adjusting for other factors, heart failure (grade 3-4) was an independent risk factor for immune-related myocarditis (HR: 6.655, 95% CI: 1.539-28.770, p=0.011). Conclusion: Patients with ICI-associated myocarditis had multi-organ irAEs with a high incidence of severe myocarditis, mortality, and poor prognosis. Thymoma was prone to those patients with multiple organs involvement. Patients could benefit from early corticosteroid intervention. Heart failure (grade 3-4) was an independent risk factor for OS after myocarditis.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2022) conducted an observational in Immune checkpoint inhibitor (ICI)-associated myocarditis (n=46). Heart failure (grade 3-4) was evaluated on Overall survival (OS) after myocarditis (HR 6.655, 95% CI 1.539-28.770, p=0.011). Heart failure (grade 3-4) was an independent risk factor for overall survival after immune checkpoint inhibitor-associated myocarditis.
Synapse has enriched 10 related papers. Consider them for comparative context: